LifeQuest World Corporation: A Pathbreaking Wastewater Treatment Technology Player

With the global population on the rise, the demand for fresh water is also increasing and is expected to double by 2050. Increasing industrialization across the globe has led to an increased quantity of pollutants entering the sources of fresh water. Given the fact that only 3% of the total water on the surface of the earth is fresh water that is suitable for human consumption, water pollution has led to a rising demand for fast, efficient, and effective wastewater treatment systems across the globe. One company that has managed to develop a truly pathbreaking product within this space is LifeQuest World Corporation (OTC Markets: LQWC).

What Does LifeQuest Do?

LifeQuest World Corporation (“LifeQuest”) is a leading name within the wastewater treatment systems industry with a global footprint. The company has acquired the intellectual property of Biopipe, a disruptive and highly scalable on-site sewage wastewater treatment technology that caters to a large market ranging from large industrial facilities, resorts, hotels, corporate towers, to individual homes. The company looks to disrupt the septic tanks market by providing on-site recycling of wastewater that is free from sludge. Over the last twelve months, the company has added capability to treat industrial wastewater as well. Formed through a reverse merger transaction by Amagon ApS, LifeQuest is based in Ridgefield Park, New Jersey with partners spread across India, Bangladesh, Philippines, South Africa and other countries.

Biopipe – The Revolutionary Wastewater Treatment Technology

Biopipe technology is a unique, biological sewage wastewater treatment system, which carries out its task without the use of any chemicals. Established in 2014, the technology has emerged to be one of the simplest and cleanest technologies within this space that makes use of its patented process and proprietary combination of enzymes and bacteria to produce reusable water. Biopipe is fully automated in nature and is an odorless, virtually silent, eco-friendly solution with a wide application. The system does not even require a 24/7 human operator and requires minimal maintenance and operating cost as compared to popular systems like the Moving Bed Bioreactors (MBR). Unlike all other competing technologies, Biopipe does not produce any sludge, which must be periodically removed. The water produced after Biopipe’s treatment can be used in toilets for flushing, cleaning, organic farming, irrigation, and so on. There are a lot of other benefits that Biopipe brings to the table given the fact that it is an onsite wastewater treatment technology. Its system can be customized to fit the needs of the client whether it is a household, an office, or a large hotel. It can scale from 300 gallons per day to 300,000 gallons per day and due to the modular design additional capacity can be easily added. Furthermore, a plant can be decommissioned and moved to another site. The essential utilities of Biopipe led to LifeQuest acquiring its intellectual property in June 2019 and the company has not looked back ever since.

The company has a joint venture with Abrimix, which has a highly efficient and cost-effective technology for treating a variety of industrial wastewater.

LifeQuest’s Growth Strategy

LifeQuest has adopted a methodical approach and is going after the water stressed countries of the world using the equity joint venture method. It has established joint ventures in the United States, India, Bangladesh, South Africa, and Ethiopia for the manufacture and distribution of its Biopipe wastewater treatment systems. Countries like India and Bangladesh have large population and also have huge wastewater treatment deficits. For example, India generates circa 23.5 billion gallons per day of sewage wastewater but has treatment capacity of only 8.7 billion gallons per day. There is an immense need for wastewater treatment. Some of its key joint ventures include names like Abrimix in South AfricaHydros Agritech in the US, and many more. LifeQuest is looking to expand its reach through 2 models – the BOOT i.e. the Build-Own-Operate-Transfer model and the BOO i.e. the Build-Own-Operate model. The best part of these models is that a customer does not have to make upfront capital investment and operations and maintenance is carried out by Lifequest on a long-term basis. This will help to accelerate market penetration and ensure recurring revenue stream.  The presence of strong joint venture partners in the regions ensures the company can deliver on the maintenance of the systems supplied to clients. With respect to the U.S., which is LifeQuest’s home market, the company plans to disrupt the septic tank market with its offerings. Biopipe is one of the most reasonable wastewater treatment systems available in the market today. The cost of the unit is well below septic tanks, which can cost between $10,000 and $45,000 and a 25,000 gpd system can cost up to $250,000  Maintenance costs associated with Biopipe are also significantly lower because there is no dosing of chemicals and sludge removal. The removal of sludge from a septic tank costs approximately $400 per visit. LifeQuest has a huge total addressable market in the U.S. and Canada and certainly in the countries it has a presence in.

Joint Venture with Hydros Agritech

The LifeQuest management recently made a big breakthrough with respect to its expansion in the U.S. market when it announced the joint venture with Hydros Agritech, a California-based provider of wastewater treatment and clean-tech systems for the agricultural market. Through this joint venture, the companies will be marketing the Biopipe technology in North America, the Caribbean, and other U.S. territories. The joint venture is making rapid progress as LifeQuest is already in the process of installing a Biopipe plant in Napa Valley, which will also serve as a reference site for   sales and marketing, not just in California but other states as well. The western half of the U.S. is suffering from significant water stress. The wine industry is an excellent target market for LifeQuest which is why the distribution of Biopipe across vineyards in Napa Valley could provide a significant boost to its revenues. Vineyard owners recognize the fact that Biopipe’s process produces water that can be reused in agriculture, and will eliminate leach fields and need for evaporative ponds. In fact, it can also assist farmers and vineyard owners in returning agricultural lands to productive use. After the installation process in the Napa Valley plant is complete, the management is confident that the system will comfortably meet the strict discharge standards of the California Water Boards with respect to water quality. A successful outcome with one of the strictest water resource control boards in the U.S. will act as a big selling point for LifeQuest when it comes to approvals in other states. This announcement comes after the company’s previous tie-up with CII-Triveni Water Institute in India to lay the foundation for marketing Biopipe in India. The deal that took place in May 2020, helped provide LifeQuest with access to the $12 billion Indian wastewater treatment market and government projects.

Strong Macro for Wastewater Treatment

With environmental challenges like global warming, increasing industrialization and urbanization, emergence of new diseases like the COVID-19, it is evident that tough times lie ahead for humanity. The fact that hardly 3% of the water available on this planet is fresh water and only 0.4% can be used by our fast-growing population indicates a strong need for wastewater treatment solutions that are low-cost, effective, and have a broad application. This is the reason why the global water and wastewater treatment market is expected to grow at a CAGR of 6.5% from 2019 to reach $211.3 billion by 2025. There is little doubt of this given the fact that an estimated 1.8 billion people will live in areas plagued by water scarcity, with two-thirds of the world’s population living in water-stressed regions by 2025. If we look further ahead, 2050 portrays an even more scary picture. With the global population growing from 7.4 billion today to about 9.1 billion in 2050, food production is expected to increase by 60%and demand for water in manufacturing is expected to increase by nearly 400%. Thus, a product like Biopipe which can recycle, and reuse wastewater has its worth in gold in the time of such an acute water crisis across the globe.

Final Thoughts

LifeQuest is at a very interesting juncture today. Despite all its volatility, the company’s stock price has remained more or less flat as the company gears itself to increase its presence in some of the largest water consumption markets in the world like US, Canada, and high water-stress and treatment deficit countries like India, Bangladesh and South Africa. It is worth highlighting that for the year ended May 31, 2019, LifeQuest was close to breakeven with a gross margin above 60%. As the operations begin to scale up, the LifeQuest stock, which is trading at hardly 29 cents a share, is bound to multiple and sail over the $1 mark. Given the huge addressable market and the management’s promising growth strategy for a unique, patented product, and a portfolio of wastewater treatment technologies, LifeQuest looks to be a very compelling investment proposition at current levels.

Disclaimer

This website is a wholly owned subsidiary of SCD Media, LLC, herein referred to as Smallcaps Daily. Our publications are a commercial advertisement and are for general information purposes ONLY. We are engaged in the business of marketing and advertising companies for monetary compensation. We may receive compensation for this article on a PPC basis as an affiliate. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our services, joining our site or our email/blog list as well as any social networking platforms we may use. PLEASE NOTE WELL: Smallcaps Daily and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever.Release of Liability: Through use of this website viewing or using you agree to hold Smallcaps Daily, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Smallcaps Daily encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and Smallcaps Daily makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provided herein. Instead Smallcaps Daily strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D. Smallcaps Daily is compliant with the Can Spam Act of 2003. Salesparq, LLC does not offer such advice or analysis, and Smallcaps Daily further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results.In preparing this publication, Smallcaps Daily, has relied upon information supplied by its customers, publicly available information and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. Smallcaps Daily has not been compensated for this article. The advertisements in this website are believed to be reliable, however, Smallcaps Daily and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. Smallcaps Daily is not responsible for any claims made by the companies advertised herein, nor is Smallcaps Daily responsible for any other promotional firm, its program or its structure. Smallcaps Daily is not affiliated with any exchange, electronic quotation system, the Securities Exchange Commission or FINRA.